Kidney Dysfunction

3

Review clinical trials related to Kidney Dysfunction. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis

The primary aim of this study is to determine the safety and mechanisms of SGLT2 inhibition in individuals on peritoneal dialysis (PD) with residual kidney function (RKF).

Participants needed: 20
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: University Health Network, TorontoUpdated: May 1, 2026Locations: 1
Eligibility criteria

Signed and dated written informed consent. [+3]

Type 1 diabetes. [+13]

Status: Recruiting

The Kidney's Response to Exercise in Heat, and the Impact of Vitamin B3 on This Response

The goal of this clinical trial is to learn about the processes occurring in the kidneys while under heat stress in healthy volunteers. The main questions it aims to answer are: * How do the chemicals produced by the body change under conditions of higher versus lower heat stress? * What role does a specific area of the body's metabolism, known as NAD+ metabolism, play in the body's response to heat stress, and can this response be modified by taking vitamin B3?

Participants needed: 28
Trial details
Phase: Early Phase 1Age: 18-45Biological sex: AllType: InterventionalSponsor: Beth Israel Deaconess Medical CenterUpdated: Feb 5, 2026Locations: 2
Eligibility criteria

Healthy volunteer [+6]

Medical condition preventing safe participation in exercise during heat [+2]

Status: Recruiting

Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)

Studying the causal roles of components of the renin-angiotensin-aldosterone system (including angiotensin-(1-7) (Ang-(1-7)), angiotensin-converting enzyme 2 (ACE2), Ang II, and ACE), uric acid, and klotho in pediatric hypertension and related target organ injury, including in the heart, kidneys, vasculature, and brain. Recruiting children with a new hypertension diagnosis over a 2-year period from the Hypertension and Pediatric Nephrology Clinics affiliated with Brenner Children's Hospital at Atrium Health Wake Forest Baptist and Atrium Health Levine Children's Hospital. Healthy control participants will be recruited from local general primary care practices. Collecting blood and urine samples to analyze components of the renin-angiotensin-aldosterone system (Ang-(1-7), ACE2, Ang II, ACE), uric acid, and klotho, and measuring blood pressure, heart structure and function, autonomic function, vascular function, and kidney function at baseline, year 1, and year 2. Objectives are to investigate phenotypic and treatment response variability and to causally infer if Ang-(1-7), ACE2, Ang II, ACE, uric acid, and klotho contribute to target organ injury due to hypertension.

Participants needed: 125
Trial details
Age: 7-18Biological sex: AllType: ObservationalSponsor: Wake Forest University Health SciencesUpdated: Dec 11, 2025Locations: 1
Eligibility criteria

7-18 years of age at time of enrollment [+4]

<7 years or >18 years of age at time of enrollment [+24]